Sema3C Promotes the Survival and Tumorigenicity of Glioma Stem Cells through Rac1 Activation

Summary: Different cancer cell compartments often communicate through soluble factors to facilitate tumor growth. Glioma stem cells (GSCs) are a subset of tumor cells that resist standard therapy to contribute to disease progression. How GSCs employ a distinct secretory program to communicate with a...

Full description

Bibliographic Details
Main Authors: Jianghong Man, Jocelyn Shoemake, Wenchao Zhou, Xiaoguang Fang, Qiulian Wu, Anthony Rizzo, Richard Prayson, Shideng Bao, Jeremy N. Rich, Jennifer S. Yu
Format: Article
Language:English
Published: Elsevier 2014-12-01
Series:Cell Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124714009243
_version_ 1819157849033408512
author Jianghong Man
Jocelyn Shoemake
Wenchao Zhou
Xiaoguang Fang
Qiulian Wu
Anthony Rizzo
Richard Prayson
Shideng Bao
Jeremy N. Rich
Jennifer S. Yu
author_facet Jianghong Man
Jocelyn Shoemake
Wenchao Zhou
Xiaoguang Fang
Qiulian Wu
Anthony Rizzo
Richard Prayson
Shideng Bao
Jeremy N. Rich
Jennifer S. Yu
author_sort Jianghong Man
collection DOAJ
description Summary: Different cancer cell compartments often communicate through soluble factors to facilitate tumor growth. Glioma stem cells (GSCs) are a subset of tumor cells that resist standard therapy to contribute to disease progression. How GSCs employ a distinct secretory program to communicate with and nurture each other over the nonstem tumor cell (NSTC) population is not well defined. Here, we show that GSCs preferentially secrete Sema3C and coordinately express PlexinA2/D1 receptors to activate Rac1/nuclear factor (NF)-κB signaling in an autocrine/paracrine loop to promote their own survival. Importantly, Sema3C is not expressed in neural progenitor cells (NPCs) or NSTCs. Disruption of Sema3C induced apoptosis of GSCs, but not NPCs or NSTCs, and suppressed tumor growth in orthotopic models of glioblastoma. Introduction of activated Rac1 rescued the Sema3C knockdown phenotype in vivo. Our study supports the targeting of Sema3C to break this GSC-specific autocrine/paracrine loop in order to improve glioblastoma treatment, potentially with a high therapeutic index. : Glioma stem cells (GSCs) have a high capacity for self-renewal, invasion, and survival. How they communicate with each other to survive and maintain their identity is not clear. Man et al. now show that GSCs have co-opted a neurodevelopmental program to activate Rac1 to promote defining features of GSCs.
first_indexed 2024-12-22T16:15:18Z
format Article
id doaj.art-2083a50321224e64bca9da501aa446ba
institution Directory Open Access Journal
issn 2211-1247
language English
last_indexed 2024-12-22T16:15:18Z
publishDate 2014-12-01
publisher Elsevier
record_format Article
series Cell Reports
spelling doaj.art-2083a50321224e64bca9da501aa446ba2022-12-21T18:20:22ZengElsevierCell Reports2211-12472014-12-019518121826Sema3C Promotes the Survival and Tumorigenicity of Glioma Stem Cells through Rac1 ActivationJianghong Man0Jocelyn Shoemake1Wenchao Zhou2Xiaoguang Fang3Qiulian Wu4Anthony Rizzo5Richard Prayson6Shideng Bao7Jeremy N. Rich8Jennifer S. Yu9Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USADepartment of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USADepartment of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USADepartment of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USADepartment of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USADepartment of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USADepartment of Anatomic Pathology, Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA; Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USADepartment of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA; Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USADepartment of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA; Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USADepartment of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA; Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA; Corresponding authorSummary: Different cancer cell compartments often communicate through soluble factors to facilitate tumor growth. Glioma stem cells (GSCs) are a subset of tumor cells that resist standard therapy to contribute to disease progression. How GSCs employ a distinct secretory program to communicate with and nurture each other over the nonstem tumor cell (NSTC) population is not well defined. Here, we show that GSCs preferentially secrete Sema3C and coordinately express PlexinA2/D1 receptors to activate Rac1/nuclear factor (NF)-κB signaling in an autocrine/paracrine loop to promote their own survival. Importantly, Sema3C is not expressed in neural progenitor cells (NPCs) or NSTCs. Disruption of Sema3C induced apoptosis of GSCs, but not NPCs or NSTCs, and suppressed tumor growth in orthotopic models of glioblastoma. Introduction of activated Rac1 rescued the Sema3C knockdown phenotype in vivo. Our study supports the targeting of Sema3C to break this GSC-specific autocrine/paracrine loop in order to improve glioblastoma treatment, potentially with a high therapeutic index. : Glioma stem cells (GSCs) have a high capacity for self-renewal, invasion, and survival. How they communicate with each other to survive and maintain their identity is not clear. Man et al. now show that GSCs have co-opted a neurodevelopmental program to activate Rac1 to promote defining features of GSCs.http://www.sciencedirect.com/science/article/pii/S2211124714009243
spellingShingle Jianghong Man
Jocelyn Shoemake
Wenchao Zhou
Xiaoguang Fang
Qiulian Wu
Anthony Rizzo
Richard Prayson
Shideng Bao
Jeremy N. Rich
Jennifer S. Yu
Sema3C Promotes the Survival and Tumorigenicity of Glioma Stem Cells through Rac1 Activation
Cell Reports
title Sema3C Promotes the Survival and Tumorigenicity of Glioma Stem Cells through Rac1 Activation
title_full Sema3C Promotes the Survival and Tumorigenicity of Glioma Stem Cells through Rac1 Activation
title_fullStr Sema3C Promotes the Survival and Tumorigenicity of Glioma Stem Cells through Rac1 Activation
title_full_unstemmed Sema3C Promotes the Survival and Tumorigenicity of Glioma Stem Cells through Rac1 Activation
title_short Sema3C Promotes the Survival and Tumorigenicity of Glioma Stem Cells through Rac1 Activation
title_sort sema3c promotes the survival and tumorigenicity of glioma stem cells through rac1 activation
url http://www.sciencedirect.com/science/article/pii/S2211124714009243
work_keys_str_mv AT jianghongman sema3cpromotesthesurvivalandtumorigenicityofgliomastemcellsthroughrac1activation
AT jocelynshoemake sema3cpromotesthesurvivalandtumorigenicityofgliomastemcellsthroughrac1activation
AT wenchaozhou sema3cpromotesthesurvivalandtumorigenicityofgliomastemcellsthroughrac1activation
AT xiaoguangfang sema3cpromotesthesurvivalandtumorigenicityofgliomastemcellsthroughrac1activation
AT qiulianwu sema3cpromotesthesurvivalandtumorigenicityofgliomastemcellsthroughrac1activation
AT anthonyrizzo sema3cpromotesthesurvivalandtumorigenicityofgliomastemcellsthroughrac1activation
AT richardprayson sema3cpromotesthesurvivalandtumorigenicityofgliomastemcellsthroughrac1activation
AT shidengbao sema3cpromotesthesurvivalandtumorigenicityofgliomastemcellsthroughrac1activation
AT jeremynrich sema3cpromotesthesurvivalandtumorigenicityofgliomastemcellsthroughrac1activation
AT jennifersyu sema3cpromotesthesurvivalandtumorigenicityofgliomastemcellsthroughrac1activation